A mouse model for donor lymphocyte infusion reveals that a single immunodom
inant minor H antigen is responsible for the beneficial effects of donor T
lymphocytes against host leukemia. Separating the good from the bad could m
ean the end of graft-versus-host disease in bone marrow transplants.